Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Dexpramipexole Dose-Ranging Biomarker Study in Subjects With Eosinophilic Asthma

ClinicalTrials.gov ID: NCT04046939

Public ClinicalTrials.gov record NCT04046939. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 4:51 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Biomarker Study of the Effects of Dexpramipexole on Eosinophils in Subjects With Eosinophilic Asthma

Study identification

NCT ID
NCT04046939
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Knopp Biosciences
Industry
Enrollment
534 participants

Conditions and interventions

Interventions

  • Dexpramipexole Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 74 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 14, 2019
Primary completion
Dec 2, 2020
Completion
Mar 1, 2021
Last update posted
Apr 12, 2023

2019 – 2021

United States locations

U.S. sites
36
U.S. states
18
U.S. cities
33
Facility City State ZIP Site status
Research Site Los Angeles California 90048
Research Site Mission Viejo California 92691
Research Site Westminster California 92683
Research Site Denver Colorado 80230
Research Site Daytona Beach Florida 32117
Research Site Miami Florida 33186
Research Site Orlando Florida 32803
Research Site Tampa Florida 33612
Research Site Tampa Florida 33634
Research Site Lawrenceville Georgia 30046
Research Site Winder Georgia 30680
Research Site Boise Idaho 83706
Research Site Farmington Hills Michigan 48336
Research site Plymouth Minnesota 55441
Research Site St Louis Missouri 63110
Research Site St Louis Missouri 63141
Research Site Las Vegas Nevada 89119
Research Site New Brunswick New Jersey 08901
Research Site Corning New York 14830
Research Site New Hyde Park New York 11042
Research Site Raleigh North Carolina 27607
Research Site Winston-Salem North Carolina 27103
Research Site Cincinnati Ohio 45231
Research Site Cincinnati Ohio 45242
Research Site Columbus Ohio 43235
Research Site Dublin Ohio 43016
Research Site Edmond Oklahoma 73034
Research Site Medford Oregon 97504
Research Site Portland Oregon 97202
Research Site Pittsburgh Pennsylvania 15205
Research Site Anderson South Carolina 29621
Research Site North Charleston South Carolina 29406
Research Site Allen Texas 75013
Research Site Boerne Texas 78006
Research Site Dallas Texas 75240
Research Site El Paso Texas 79902

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04046939, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 12, 2023 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04046939 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →